The role of tumor volume in 'reoxygenation' upon cyclophosphamide treatment

Acta Oncol. 1995;34(3):405-8. doi: 10.3109/02841869509093998.


The effect of cyclophosphamide (CP) injection (60 mg/kg i.p., single dose) on volume growth and tissue oxygenation (pO2 distribution) was investigated in rat DS-sarcomas. CP was administered 4 days after subcutaneous (s.c.) tumor implantation (volume approximately 0.35 ml). Polarographic pO2 measurements were performed in the subcutis at the hind foot dorsum and in tumors 72 h after CP administration. The oxygenation status of these tissues was compared with that of saline-treated controls. CP-injection caused a mean growth delay of 11 days in DS-sarcomas and had no impact on the oxygenation status of the subcutis. In contrast, in s.c. growing DS-sarcomas the pO2 distribution improved significantly when treated tumors (0.59 ml volume) were compared with their untreated counterparts (1.15 ml volume). Comparison of the oxygenation data of CP-treated tumors with size-matched controls revealed an identical oxygenation status in the experimental tumors used. Thus, when 'reoxygenation' is discussed, one should consider whether it is solely the result of tumor shrinkage or a volume-independent phenomenon.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Pressure / drug effects
  • Carbon Dioxide / blood
  • Cell Division / drug effects
  • Cyclophosphamide / pharmacology*
  • Female
  • Hematocrit
  • Hemoglobins / metabolism
  • Kinetics
  • Male
  • Oxygen / analysis
  • Oxygen / blood
  • Oxygen Consumption / drug effects*
  • Partial Pressure
  • Polarography
  • Rats
  • Rats, Sprague-Dawley
  • Sarcoma, Experimental / blood supply
  • Sarcoma, Experimental / drug therapy
  • Sarcoma, Experimental / metabolism*
  • Sarcoma, Experimental / pathology*
  • Time Factors


  • Hemoglobins
  • Carbon Dioxide
  • Cyclophosphamide
  • Oxygen